The p53 tumor suppressor plays a key role in the cell's response to genotoxic stress and loss of this`guardian of the genome' is an important step in carcinogenesis. The ability of p53 to induce apoptosis through transactivation of its target genes is critical for its function as tumor suppressor. We have found that overexpression of p53 in human cancer cell lines resulted in apoptosis as measured by PARP cleavage. Furthermore we observed cleavage of both caspase 9 and caspase 8 after overexpression of p53 and found that p53-dependent apoptosis was inhibited by either cellular (c-Flip-s, Bcl-X L ) or pharmacological inhibitors of caspase 8 or caspase 9 respectively. These results indicate that p53 is mediating apoptosis through both the mitochondrial and death receptor pathways. To elucidate the relevant p53 target genes and examine the caspase pathways utilized in vivo, we treated p53+/+ and age matched p537/7 mice with 5 Gy ionizing radiation or 0.5 mg/animal dexamethasone and harvested tissues at 0, 6 and 24 h. We examined the mRNA expression of p21, bax, KILLER/DR5, FAS/APO1 and EI24/PIG8 using TaqMan real time quantitative RT ± PCR in the spleen, thymus and small intestine. Although the basal mRNA levels of these genes did not depend on the presence of p53, we observed a p53-dependent induction of all these targets in response to g-irradiation and a p53-independent regulation for p21 and KILLER/ DR5 in response to dexamethasone. Furthermore, we have demonstrated that the relative induction of these p53 target genes is tissue speci®c. Despite observing otherwise similar levels of death in these tissues, our ®ndings suggest that in some cases apoptosis mediated through p53 occurs by redundant pathways or by à group eect' while in other tissues one or few targets
Introduction
The p53 tumor suppressor has been shown to play a key role in mediating apoptosis induced by a variety of cellular and extracellular signals including genotoxic stress and inappropriate proliferative signals (reviewed in Burns and El-Deiry, 1999) . Mutation or loss of p53 has been observed in over 50% of all tumors and almost every tumor type (Hollstein et al., 1991) . Furthermore, it has been estimated that the p53 pathway is disrupted by mutation or inhibition of its function in the vast majority of tumors (Vogelstein and Kinzler, 1992) . Hereditary loss of p53 results in LiFraumeni syndrome which is characterized by a greater than 50% incidence of neoplasia by the age of 30 (Malkin et al., 1990) . Although animals in which the p53 locus has been deleted develop normally, 75% of the p53-null animals develop tumors by six months of age and all the p53-null animals develop tumors and die by 10 months of age (Donehower et al., 1992) . Loss of p53 or disruption of the p53 pathway is clearly a critical step in carcinogenesis.
p53 mediates many of its key functions through the transactivation of its target genes. Although p53 can, in some situations, induce apoptosis in the absence of transactivation (Haupt et al., 1995 (Haupt et al., , 1996 or de novo mRNA or protein synthesis (Caelles et al., 1994) , most tumor-derived mutants of p53 are defective in DNA binding and transactivation, supporting a critical role for transactivation in p53's ability to suppress neoplasia. In response to DNA damage, cells can either undergo G1 cell cycle arrest (Kastan et al., 1991) or apoptosis (Clarke et al., 1993; Lowe et al., 1993) . p53-dependent G1 arrest is primarily mediated by p21WAF1, a cyclin dependent kinase inhibitor (ElDeiry et al., 1993) . The target genes and pathways which mediate p53-dependent apoptosis are less well understood.
Several p53 target genes have been proposed to mediate p53-dependent apoptosis. These target genes tend to fall into two major classes based on the caspase pathway they mediate their eects through (see Thornberry and Lazebnik, 1998) Bax, a proapoptotic member of the Bcl-2 family, is the best characterized mediator of p53-dependent apoptosis (Miyashita and Reed, 1995) . Bax mediates cell death through the induction of Cytochrome c release from the mitochondria which results in the activation of caspase 9 (for review see Adams and Cory, 1998) . Although bax has been shown to be regulated by p53, it is not required in most forms of p53-mediated apoptosis. Bax7/7 thymocytes and colonic epithelia are not defective in gamma irradiation-induced apoptosis while p537/7 thymocytes and colonic epithelia are severely impaired (Knudson et al., 1995; Pritchard et al., 1999) . However, Bax does seem to be required for p53-dependent apoptosis in the developing central nervous system after g-irradiation (Chong et al., 2000) and contributes to DNA damage-induced apoptosis in E1A expressing ®broblasts (McCurrach et al., 1997) . Clearly there are other genes which mediate p53-dependent apoptosis. Several other p53 target genes have also been shown to function through the mitochondrial death pathway including a recently discovered pro-apoptotic bcl-2 family member, Noxa (Oda et al., 2000) . EI24/PIG8 isolated independently from mouse and human cells as a p53 target gene also appears to mediate its eects through the mitochondrial pathway (Lehar et al., 1996; Polyak et al., 1997; Gu et al., 2000) . Two p53 targets have been shown to mediate cell death through the death receptor pathway. Fas/APO1, a member of the tumor necrosis factor (TNF) receptor family, was found to be regulated by p53 by both transcriptional and transcription-independent mechanisms (Owen-Schaub et al., 1995; Bennett et al., 1998) . However, Fas/APO1 does not appear to be required for p53-dependent apoptosis in response to DNA damage (Fuchs et al., 1997) . KILLER/DR5 is a proapoptotic member of the TRAIL (TNF-related apoptosis-inducing ligand) receptor family and was identi®ed in a subtractive hybridization screen for p53 target genes (Wu et al., 1997) . Both Fas/APO1 and KILLER/DR5 transduce their death signals through the formation of a death-inducing signaling complex (DISC) which includes the receptor, an adaptor molecule and caspase 8 (for review, see Ashkenazi and Dixit, 1998) . Ligation of the receptor leads to activation of caspase 8 and subsequent activation of caspase 3 which results in apoptosis. Caspase 8 has also been shown to cleave the pro-apoptotic bcl-2 family member, Bid, which leads to the activation of caspase 9 through the mitochondrial pathway (Li et al., 1998) . Therefore activation of the death receptor pathway can induce its signal through both mitochondria-dependent and-independent pathways.
Several lines of evidence have suggested that the mitochondrial pathway is required for p53-dependent apoptosis. Studies using the caspase 97/7 animals have shown that caspase 9 is required for gammairradiation induced apoptosis in two tissues (spleen and thymus) which undergo p53-dependent apoptosis after irradiation (Hakem et al., 1998) . Furthermore, both Apaf-1 and caspase 9 were shown to be required for p53-dependent apoptosis after oncogene overexpression in MEFs (Soengas et al., 1999) . The role of caspase 8 in p53-dependent apoptosis is unclear since similar irradiation studies have not been performed in the caspase 87/7 animals (Varfolomeev et al., 1998) . However given the known p53 targets which act through caspase 8 it is likely that caspase 8 plays a role in mediating p53-dependent apoptosis. In this study we examined the role of both caspase 8 and 9 in p53-dependent apoptosis in two human cancer cell lines and investigated the expression of several p53 target genes involved in apoptosis in an in vivo model of p53-dependent apoptosis. We have found that both caspase 8 and caspase 9 are cleaved during p53-dependent apoptosis and that speci®c inhibitors of the activity of each, block p53-dependent apoptosis. Furthermore, we have examined the expression of the p53 target genes: p21, bax, E124/PIG8, FAS/APO1 and KILLER/DR5 after irradiation of p53-wild-type and-null animals. We have found a striking tissuespeci®c expression pattern for these apoptotic target genes. Our ®ndings suggest that KILLER/DR5 may play a key role in mediating p53-dependent apoptosis in vivo, for example in the spleen and small intestine where its transcriptional induction following g-irradiation predominates among the known pro-apoptotic targets examined. These results suggest a role for both the death receptor and mitochondrial pathways in mediating p53-dependent apoptosis.
Results

p53 mediates apoptosis through both the mitochondrial and death receptor pathways
In order to examine the downstream caspases through which p53 induces cell death, we infected human cancer cell lines lacking wild-type p53 with an adenovirus expressing wild-type p53 or a control adenovirus containing the LacZ gene. In both the colon carcinoma cell line, SW480 and the breast carcinoma cell line, SKBR3 overexpression of p53 resulted in apoptosis by 48 h as evidenced by cleavage of the caspase 3 substrate, PARP (Figure 1a) . To elucidate the downstream caspases which are cleaved during p53-mediated apoptosis, we examined the cleavage of caspase 8 and caspase 9 after Ad-p53 infection. Western blot analysis revealed that both caspase 8 and caspase 9 were cleaved during p53-dependent apoptosis (Figure 1b) . Furthermore, the cleavage of caspase 8 appeared to precede the cleavage of caspase 9 suggesting that activation of caspase 8 may be independent of caspase 9 activation.
To determine the relative contributions of caspase 8 and caspase 9 to p53-induced cell death, we overexpressed p53 in SW480 cell lines that stably over-expressed either c-FLIP-s or Bcl-X L which are speci®c inhibitors of caspase 8 and caspase 9 activation respectively (Irmler et al., 1997; Kluck et al., 1997; Zou et al., 1997; Tschopp et al., 1998; Adams and Cory, 1998) . Either overexpression of c-Flip-s or Bcl-X L was able to partially inhibit p53-mediated death after Ad-p53 infection (Figure 1c ). Furthermore we examined the ability of speci®c irreversible inhibitors of caspase 8 (Z-IETD-FMK) and caspase 9 (Z-LETD-FMK) to inhibit p53-dependent apoptosis ( Figure 1d ). Overexpression of p53 results in apoptosis in the adrenal carcinoma cell line, SW13, which could be inhibited by either a caspase 8 or caspase 9 inhibitor ( Figure 1d ). These results further support a role for the death receptor and mitochondrial pathways in mediating p53-dependent apoptosis.
Similar levels of ionizing radiation-induced p53-dependent apoptosis in vivo
To explore the role of p53 targets genes in activating the caspase cascade and inducing cell death, we used an in vivo system of p53-mediated apoptosis. The study of p53-mediated apoptosis in vivo allows one to In vivo apoptosis and KILLER/DR5 TF Burns et al examine the eects of endogenous p53 on its target genes when p53 is expressed at a physiological level. We decided to determine the relative levels of apoptosis in the thymus and spleen which have previously been shown to undergo a p53-dependent apoptosis in response to ionizing radiation (Lowe et al., 1993 , Midgley et al., 1995 . We treated p53+/+ and age matched p537/7 mice with 5 Gy of ionizing radiation or dexamethasone and harvested tissues at 0, 6, and 24 h after treatment. We con®rmed that ionizing radiation results in a p53-dependent apoptosis in the thymus and spleen as PARP cleavage was only observed in tissues from p53+/+ animals ( Figure 2 ). Furthermore we observed similar levels of apoptosis as measured by PARP cleavage in thymus and spleen ( Figure 2 ). Because similar levels of apoptosis were present in these tissues, we decided to determine whether the gene expression pattern of known p53 target genes involved in apoptosis were similar after treatment with ionizing radiation in vivo.
p53 target genes involved in apoptosis are expressed in a p53-dependent and tissue-specific manner following exposure to g irradiation in vivo We analysed the mRNA expression level of ®ve p53 target genes in three tissues which undergo p53-dependent apoptosis. We chose to analyse p21WAF1, bax, Fas/APO1, KILLER/DR5 and E124/PIG8. p21WAF1 is a known cyclin-dependent kinase inhibitor involved in p53-dependent growth arrest while the other four targets have been implicated in p53-dependent apoptosis (El-Deiry et al., 1993; Zhao et al., 2000) . Bax and EI24/PIG8 have previously been shown to mediate cell death through the caspase 9 and the mitochondrial pathway while Fas/AP01 and KILLER/ DR5 induce death through caspase 8 (reviewed in Burns and El-Deiry, 1999) . To determine the mRNA expression levels of the ®ve targets we developed a TaqMan real-time quantitative RT ± PCR assay with expression levels of p53 target genes normalized to endogenous GAPDH mRNA levels. The result of four independent trials revealed that in the spleen, thymus and small intestine, there was no statistically signi®cant dierence in the basal expression level of the ®ve p53-target genes in p53+/+ and p537/7 animals (data not shown). We next examined the expression of these ®ve p53-target genes after treatment with dexamethasone or 5 Gy of ionizing radiation in p53 wild-type and p53 null animals.
Previous studies and our data above (Figure 2 ) have shown that the spleen undergoes p53-dependent apoptosis after g-irradiation (Midgley et al., 1995) . We examined the expression of p21WAF1 and found as expected it was strongly induced after 5 Gy in the p53+/+ animals by 6 h and was still elevated 24 h after treatment but was unchanged in p537/7 animals ( Figure 3a) . Interestingly, p21WAF1 was also induced over fourfold by dexamethasone treatment at 6 h in a p53 independent manner (Figure 3a) . However, the dexamethasone treatment did not cause cell death in the spleen (Figure 2 ). We next examined the expression levels of bax, Fas/APO1, KILLER/DR5 and EI24/ PIG8. Although these four apoptosis-inducing genes were upregulated in a p53-dependent manner after girradiation they diered greatly in their extent of induction. While the mRNA levels of bax and EI24 were elevated approximately fourfold at 6 h, the mRNA level of mouseKILLER/DR5 (MK) was increased almost 30-fold at 6 h after g-irradiation.
The p53-dependent induction after irradiation of mouseKILLER/DR5 agrees with previous published reports that the KILLER/DR5 promoter contains p53 binding sites and that KILLER/DR5 is induced in a p53-dependent manner after DNA damage in human and mouse tumor cell lines (Wu et al., 1997 (Wu et al., , 1999 Takimoto and El-Deiry, 2000) . In contrast, Fas/APO1 was only weakly induced (2.4-fold) by g-irradiation in the spleen (Figure 3b ). Western blot analysis for p21 and bax con®rmed that these targets were induced in a Oligonucleotide microarray analysis of total RNA from the spleen of irradiated and untreated p53+/+ and p537/7 animals for p21, mdm2, FAS/APO1, bax, and ei24/pig8. The chart depicts the fold induction of p21, mdm2, FAS/APO1, bax, and ei24/pig8 6 h after 5 Gy irradiation relative to the wild type untreated animals p53-dependent manner (Figure 3c ). Furthermore microarray analysis con®rmed that p21, bax, FAS/ APO1, EI24/PIG8 as well as mdm2 exhibited a similar pattern of induction relative to each other as observed by Taqman RT ± PCR assay (Figure 3d , data not shown). These results suggest that KILLER/DR5 may play a more signi®cant role in mediating p53-dependent apoptosis in the spleen as compared to other targets such as bax or FAS/APO1. We next analysed the expression pattern of p21WAF1, bax, Fas/APO1, KILLER/DR5 and EI24/ PIG8 in the thymus after g-irradiation. The mRNA expression of p21WAF1 was dramatically increased by 6 h and remained elevated at 24 h after g-irradiation in
In vivo apoptosis and KILLER/DR5 TF Burns et al a p53-dependent manner ( Figure 4a ). As observed in the spleen, p21 mRNA was also induced by dexamethasone treated in a p53-independent manner (Figure 4a ). Several studies have demonstrated that dexamethasone treatment results in a p53-independent apoptosis (Lowe et al., 1993) . Interestingly, KILLER/ DR5 was also induced by dexamethasone at 24 h after treatment in a p53-independent manner (Figure 4b ). This agrees with previous studies in human cancer cell lines where it was observed that dexamethasone induced apoptosis correlated with KILLER/DR5 induction regardless of p53 status (Meng and El-Deiry, 2001 ). As observed in the spleen, all ®ve p53 target genes were induced in the thymus by ionizing radiation in a p53-dependent manner. However, unlike the spleen, all four of the apoptotic targets examined were increased by at least sevenfold at 6 h ( Figure 4b ). KILLER/DR5 was again induced almost 30-fold at 6 h after irradiation and remained elevated 24 h after treatment. Bax mRNA was also signi®cantly increased (15.7-fold) and remained elevated at 24 h. Microarray analysis con®rmed these ®ndings as p21, bax, FAS/APO1, EI24/PIG8 as well as mdm2 exhibited a similar pattern of induction relative to each other as observed by Taqman RT ± PCR assay ( Figure 4d , data not shown). It is possible that some post-transcriptional mechanism may further regulate the levels of Bax protein. Western blot analysis for p21 and bax con®rmed that the target proteins were induced in a p53-dependent manner, however, Bax protein did not seem to be as signi®cantly induced compared to the induction observed at the mRNA level (Figure 4c ). These results suggest that several target genes may be making a signi®cant contribution to the p53 induced cell death in the thymus. Finally we examined small intestine in which cells of epithelial origin have been shown to undergo p53-dependent apoptosis after exposure to g-radiation (Pritchard et al., 1999) . Although p53-dependent apoptosis was observed in the small intestine after ionizing radiation, KILLER/DR5 was the only p53 target gene whose mRNA levels signi®cantly increased after g-irradiation (Figure 5a,b) . KILLER/DR5 mRNA was induced 10-fold at 6 h after irradiation and remained elevated at 24 h. Western blot analysis for p21 and bax con®rmed these results as p21 was only weakly induced and Bax protein levels did not signi®cantly change (Figure 5c ). These results suggest a potentially unique role for KILLER/DR5 in mediating p53-dependent apoptosis in the small intestine following exposure to g-radiation.
Discussion
To examine the mediators of p53-dependent apoptosis we have used both tissue culture and in vivo models of p53-dependent cell death. Previous studies have shown an important and in some cases essential role for the mitochondria and caspase 9 in p53 induced apoptosis (Hakem et al., 1998; Soengas et al., 1999) . The role of caspase 8 in p53-dependent death is not well understood. Two target genes of p53 studied here, KILLER/DR5 and FAS/APO1, signal through cleavage of caspase 8 and when overexpressed lead to massive apoptosis (Wu et al., 1997 , Owen-Schaub et al., 1995 . In this study, we have shown that caspase 8 is cleaved at the same time or earlier than caspase 9 after p53 overexpression, indicating that p53 is not activating caspase 8 through caspase 9 and 3 indirectly. Furthermore, both caspase 8 and caspase 9 appear to contribute to the observed p53-mediated cell death as either inhibitors of caspase 8 and caspase 9 activity respectively blocked p53-mediated apoptosis. Since this model of p53-dependent apoptosis depended on overexpression of p53 above physiological levels, we next examined a model of endogenous p53-dependent apoptosis in vivo.
Our in vivo studies suggest that p53-dependent apoptosis may occur through dierent mediators depending on the tissue type. Furthermore, our ®ndings suggest that in some cases apoptosis mediated through p53 may occur by redundant pathways or by à group eect' while in other tissues one or few targets may play a key role in p53-dependent apoptosis. There is some support for a single target gene being essential as studies in the CNS revealed a key role for bax in mediating p53-dependent apoptosis (Chong et al., 2000) . The tissue type dierences we observed in the expression of p53 target genes cannot be explained by dierences in the amount of apoptosis in each tissue as we observed similar levels of death after irradiation in the spleen and thymus. In the thymus we found that bax, EI24/PIG8, FAS/APO1 and KILLER/DR5 in irradiated thymus are signi®cantly induced, suggesting that p53 mediates its cell death through several redundant targets. Because p53 induces all of these genes strongly in the thymus one would predict that the loss of a single target would not attenuate p53-dependent apoptosis. Previous studies agree with this prediction as either bax or FAS/APO1 but not p53 were dispensable in the thymus for DNA damageinduced cell death (Knudson et al., 1995; Fuchs et al., 1997 ) However, it is still possible that a single target gene may be essential for apoptosis, as knockout animals of many p53 target genes including KILLER/ DR5 and EI24/PIG8
have not yet been tested in gradiation experiments. In contrast to the thymus, the spleen and small intestine exhibit a more restrictive expression pattern of p53 target genes during apoptosis. In spleen, Fas/APO, EI24/PIG8 and bax were either induced weakly or not at all. KILLER/DR5 was strongly induced and was the dominant induced apoptotic p53 target gene in these tissues. In the small intestine, an example of p53-dependent death in epithelial tissue, KILLER/DR5 was the only p53 target gene examined in this study which was induced. These results suggests that in these two tissues, one or few p53 target genes may be essential for p53-dependent death. There are no published reports that either FAS/APO1 or bax is required for apoptosis after ionizing radiation in the spleen. However, the weak induction of these target genes and EI24 suggests that they probably are not playing a key role in p53-dependent apoptosis in these tissues. Previous studies in the small intestine have shown that bax is not required for p53-dependent apoptosis (Pritchard et al., 1999) . This result agrees with our ®ndings that bax is not signi®cantly induced in the small intestine. Our evidence suggests a key role for KILLER/DR5 in mediating p53-dependent apoptosis in the spleen and especially the small intestine. Whether KILLER/DR5 is an essential gene for mediating p53-dependent death or one of a few critical targets remains to be determined by examining the KILLER/ DR5 knockout animals for defects in radiation induced apoptosis. It is possible that the requirement for one or multiple target genes in a particular tissue may be dependent upon the balance of pro-or anti-apoptotic molecules in that particular tissue.
Although de®nitive evidence for an essential role for most p53 targets in vivo is lacking, several animal studies have shown a critical role for caspase 9 is mediating DNA damage induced apoptosis in both the thymus and spleen (Hakem et al., 1998) . Our data suggests that in these tissues KILLER/DR5 may play an important role in mediating p53-dependent apoptosis. Since caspase 9 but not bax has been shown to be required for radiation-induced death in both the thymus and spleen, there are several possible explanations for our observations. One explanation is that another p53 target gene not tested in this study may be responsible for mediating the caspase 9 dependent death. One candidate gene is the recently discovered p53 target, Noxa, which is a BH3 containing molecule expressed in the thymus (Oda et al., 2000) . However, based on the evidence presented, Noxa is upregulated by p53 either during cell cycle arrest or apoptosis suggesting that it may be necessary but not sucient for cell death induction. Another explanation for the dissociation between a requirement for bax versus caspase 9 is that in these tissues the cleavage of Bid downstream of caspase 8 activation, for example by KILLER/DR5, leads to the eventual activation of caspase 9. Several studies have shown that both Fas and TRAIL treatment can lead to Bid cleavage and activation of caspase 9 (Li et al., 1998; Yamada et al., 1999) . Furthermore, there is at least one in vivo example in which Fas requires the mitochondrial pathway for inducing apoptosis . The requirement of KILLER/DR5 and caspase 8 in mediating p53-dependent apoptosis in the thymus and spleen can be tested by irradiating the Bid7/7 or caspase 87/7 animals and observing whether a cell death defects exists in the thymus or spleen after irradiation. However, even if Bid7/7 tissues are not de®cient in g-radiation-induced apoptosis, there may be redundant or yet to be discovered connections between the cell membrane and mitochondrial death pathways.
In the small intestine, there is no published evidence that caspase 9 is required for p53-dependent apoptosis and bcl-2 knockout animals have only a small increase in apoptosis after irradiation, suggesting that the mitochondrial pathway may not be as important in the small intestine (Pritchard et al., 1999) . Interestingly, KILLER/DR5 was the only p53 target gene examined that was signi®cantly upregulated in the small intestine following exposure to g-radiation. These results suggest that KILLER/DR5 may play a unique role in mediating p53-dependent apoptosis in the small intestine. It remains to be seen whether KILLER/ DR5 is required and whether it is dependent upon the mitochondrial pathway in radiation-induced death of the small intestine. Irradiation studies of the KILLER/ DR5 and Bid knockout animals and examination of the resulting apoptosis in the small intestine would in the future address these questions.
Given the potentially unique role of KILLER/DR5 in mediating p53-dependent death after ionizing radiation in vivo, it is not surprising that mutations of KILLER/DR5 in head and neck and cancer and in non-small cell lung cancers have been found (Pai et al., 1998; Lee et al., 1999) Further support for a potential role for KILLER/DR5 in human cancer, comes from previous reports which demonstrated that the antiapoptotic TRAIL decoy receptor, TRID/TRAIL-R3 is overexpressed in primary tumors of the gastrointestinal tract (Sheikh et al., 1999) . Because KILLER/DR5 is uniquely induced by p53 in the small intestine after girradiation it may be necessary for primary tumors of the gastrointestinal tract to upregulate TRID/TRAIL-R3 to prevent p53-dependent apoptosis (Sheikh et al., 1999; Meng et al., 2000) . It is possible that in some cases loss of KILLER/DR5 may substitute for loss of p53 or at least may increase a tumor cell's tolerance to wild-type p53.
In summary, we have demonstrated in two human tumor cell lines that both caspase 8 and caspase 9 are cleaved during p53-dependent apoptosis and that inhibitors of death receptor or mitochondrial death signaling inhibit p53-mediated cell death. Our studies in vivo have revealed striking tissue speci®c patterns of expression for p53 target genes. Our data suggests that p53-mediated apoptosis occurs in some tissues such as the thymus through redundant pathways or by à group eect' while in other tissues one or few targets may play a key role in p53-dependent apoptosis. Finally we have found evidence that KILLER/DR5 may be playing a key role in mediating p53-dependent apoptosis in vivo and may have a unique role among transcriptional targets of p53, causing cell death in response to g-irradiation in the small intestine.
Materials and methods
Animals and treatments
Healthy 6 ± 7-week old female p53+/+ and p537/7 animals were obtained from Jackson Laboratories (Bay Harbor, Maine, USA). Two animals in each experimental group received either 0.5 mg/animal of dexamethasone (Elkins-Sinn Inc, Cherry Hill, NJ, USA) or sterile 1X PBS by single bolus intraperitoneal injection. Total body irradiation was performed using a 137 Cesium g-source at a dose rate of 1.532 Gy/min. At 0, 6 and 24 h, the mice were euthanized using an approved Institutional Animal Care and Use Committee Protocol, which followed recommendations of the Panel on Euthanasia of the American Veterinary Medical Association. Tissues were harvested and snap frozen in liquid nitrogen and kept at 7808C until used.
Cell culture and adenoviral/retroviral infection
The culture conditions for SW480, HCT 116 and SkBr3 were maintained as previously described (Wu et al., 1997) . The adrenal carcinoma cell line, SW13 was a kind gift from R Sheikhattar (Wistar Institute). Ad-LacZ and Ad-p53 were obtained from B Vogelstein (Johns Hopkins University). All adenoviruses were propagated, titered, and ampli®ed as previously described (El-Deiry et al., 1993) . The retroviral vector pLIB (Clontech), pLIB-EGFP (Clontech), pLIB-cFlip-s, or pLIB-Bcl-X L was cotransfected with pVSVG and pCgP (Dr Michael Malim, University of Pennsylvania) into 293T cells using the CaPO 4 method. The resulting supernatant was used to infect the SW480 cell line (3610 5 cell/well plated 48 h before infection) at a titer necessary to obtain greater than 90% infectivity as previously described (Fouchier et al., 1997) .
Plasmids
The wildtype p53 expression vector pCEP4-p53 (El-Deiry et al., 1993) and control vector were generously supplied by Bert Vogelstein (Johns Hopkins University). The pCMVEGFPSpectrin vector was previously described (Kalejta et al., 1997) .
The Bcl-X L and c-FLIP-s (short form) (Irmler et al., 1997) genes were ampli®ed from a human placenta retroviral library (Clontech) and cloned into the Not1 site of pLIB (Clontech) respectively and fully sequenced prior to use in transfection studies.
Transfections and fluorescence-activated cell sorting (FACS) analysis
Transfections were carried out as previously described (Wu et al., 1997) . In brief, before transfection, 5610 5 cells/6 cm well were seeded. The cells were transfected with lipofectamine Plus (Life Technologies Inc.) according to the manufacturer's speci®cations. Four hours after transfections the media was changed and an irreversible caspase inhibitor, Z-IETD-FMK (caspase 8) or Z-LEHD-FMK (caspase 9) (R & D Systems) was added to the media at a ®nal concentration of 20 mM. Cells were harvested 24 h after transfection and prepared for detection of active-caspase 3 by¯ow cytometry as previously described (Ozoren et al., 2000) . For adenoviral experiments, cells were harvested 48 h after infection and ®xed and stained with propidium iodide as previously described (Ozoren et al., 2000) . Cell sorting was performed on a Coulter Epics Elite counter.
Western blotting
Total cellular protein was harvested in 16Laemmli sample buer and quantitated using the Amido Black Staining method as previously described (Meng et al., 1998) . A total of 80 mg of protein per lane was loaded on either a 10% (PARP) or 15 % SDS ± PAGE gel and electrophoresed and electroblotted as previously described (El-Deiry et al., 1994) . The following antibodies were used in these experiments: rabbit polyclonal anti-PARP (Boehringer Mannheim), mouse monoclonal anti-caspase 8 (Cell Signalling Technologies), rabbit polyclonal anti-caspase 9 (Imgenex), mouse monoclonal anti-actin (Santa Cruz), rabbit polyclonal anti-p21 (Santa Cruz), and rabbit polyclonal anti-bax (Santa Cruz).
Taqman real time quantitative RT ± PCR assay for mRNAs of p21, bax, EI24, Fas/APO1, mKILLER/DR5, and GAPDH Taqman RT ± PCR assay was conducted according to the manufacturer's speci®cations (PE Applied Biosystems). In brief, oligonucleotides (probes) for TaqMan RT ± PCR were labeled with FAM(6-carboxy¯uorescin) (p21, bax, EI24, Fas/ APO1, and mKILLER/DR5) or VIC (GAPDH) and 3' prime quencher, N, N', . The following primer and probe sequences where used for each gene respectively: mp21primers ± 5'-CGAGAACGG-TGGAACTTTGAC-3', 5'-TCCCAGACGAAGTTGCCCT-3', probe: 6FAM-TCGTCACGGAGACGCCGCTG-TAM-RA; bax primers: 5'-GGAGCAGCTTGGGAGCG-3', 5'-AAAAGGCCCCTGTCTTCATGA-3', probe: 6FAM-CGG-GCCCACCAGCTCTGAACA-TAMRA; FAS/APO1 primers: 5'-TCGGAGATGCTATTAGTACCTTGAGTAT-3', 5'-GATCTGGGCTGTCCTGCCT-3', probe: 6FAM-TGGT-GCTTGCTGGCTCACAGTTAAGAGT-TAMRA; mKIL-LER/DR5 primers: 5'-ATAAAAAGAGGCTGTGAACG-GG-3', 5'-GGTCCAAGAGAGACGA-3', probe: 6FAM-TC-CCGAAAGTGCGAACTCTGTGCA-TAMRA; EI24/PIG8 primers: 5'-GAAGGATGTGGCGAAGGGA-3', 5' CCA-CAAGACCGTCTACCTGCA-3', probe: 6FAM-CAGCCC-TGAGCAGCTCGTCCTCTG-TAMRA. Whenever possible probe and primer sets were designed over intron/exon boundaries to prevent ampli®cation of genomic DNA. All primer pairs were tested to ensure that the proper size fragment was generated. GAPDH primer and Vic labeled probe were obtained from PE Applied Biosystems. All primers and probes were designed with the use of Primer Express Version 1.0 (PE Applied Biosystems). Total RNA was isolated from individual tissues as previously described (El-Deiry et al., 1993) and 1 mg was used for reverse transcription and ampli®cation using TaqMan Reverse Transcription Reagents according to the manufacturer's protocol (PE Applied Biosystems). Total RNA samples were electrophoresed on a MOPS-formaldehyde gel and the pattern of the 28S and 18S ribosomal bands were observed to verify the quality of the total RNA preparation (El-Deiry et al., 1993) . A master mix of TaqMan reagents was prepared and 10 ng of each RT sample was used in the Taqman PCR reaction. Each tube contained both a gene probe and primers and a GAPDH control probe and primer. Each sample was done in quadruplicate. The increase in¯uorescence (D Rn) was proportional to the concentration of template in the PCR. The PCR cycle number at threshold represents CT. Reactions in which reverse transcriptase was not added to the RT rxn were used to control for genomic contamination. Any contribution of genomic contamination to the CT value for a sample was ignored since the CT value of the (7)RT rxn was at least 10 cycles less than for samples in which reverse transcriptase was added. The standard curve method was used to quantitate amounts of each gene relative to the GAPDH amount in each reaction according to the manufacturer's protocol (PE Applied Biosystems). Reactions were carried out in 96-well plates using the ABI PRISM 7700 Sequence Detection System (PE Applied Biosystems).
Oligonucleotide microarray analysis
Total RNA was isolated from individual tissues as previously described (El-Deiry et al., 1993) and ampli®ed, labeled, and hybridized to the Murine 11K gene chips as previously described (Lockhart et al., 1996; Wodicka et al., 1997) . For each RNA sample the average intensity of all genes on the chip was adjusted to 1500 to allow for comparison and subsequent analysis (Lockhart et al., 1996; Wodicka et al., 1997) . Analysis was performed using the Aymetrix Microarray Suite 4.0 according to the manufacturer's protocol.
